Fructose-rich diet leads to reduced aerobic capacity and to liver injury in rats

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Botezelli, José Diego ^a   Cambri, Lucieli Teresa ^a   Ghezzi, Ana Carolina ^a   Dalia, Rodrigo Augusto ^a   Voltarelli, Fabrício Azevedo ^b   De Mello, Maria Alice Rostom ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

Fructose; Liver injury; Oxidative stress; Rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; FRUCTOSE; GLUCOSE; INSULIN; LACTIC ACID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

AEROBIC CAPACITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARBOHYDRATE DIET; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE TOLERANCE; HISTOPATHOLOGY; INSULIN SENSITIVITY; LIVER INJURY; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ALANINE TRANSAMINASE; ANIMALS; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; CATALASE; DIETARY CARBOHYDRATES; FATTY LIVER; FRUCTOSE; GLUCOSE; INTRA-ABDOMINAL FAT; LACTIC ACID; LIPID METABOLISM; LIPID PEROXIDATION; LIPIDS; LIPOGENESIS; LIVER; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84862302929     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-78     Document Type: Article

References (52)

1. Markers and development of the metabolic syndrome. In The insulin resistance atherosclerosis study. Hanley AJG, Williams K, Festa A, Haffner SM, D'Agostino, Diabetes 2005 54 Suppl. 11 3140 3147 (Pubitemid 43334367)
2. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Angulo P, Keach JC, Batts KP, Lindor KD, Hepatology 1999 30 Suppl. 6 1356 1362
3. The prevalence and etiology of elevated aminotransferase levels in the United States. Clark JM, Brancati FL, Diehl AM, Am J Gastroenterol 2003 98 960 967 (Pubitemid 36733754)
4. Molecular mediators of hepatic steatosis and liver injury. Browning JD, Horton JD, J Clin Investig 2004 2 Suppl. 114 147 152 (Pubitemid 39071617)
5. Insulin signalling and the regulation of glucose and lipid metabolism. Saltiel AR, Khan R, Nature 2001 414 799 806 (Pubitemid 34000783)
6. Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Elliot C, Vidal-Puig AJ, Int J Obes 2004 28 22 S28
7. A high-fructose diet induces insulin resistance but not blood pressure changes in normotensive rats. Bezerra RMN, Ueno M, Silva MS, Silva MS, Tavares DQ, Carvalho CRO, Saad MJA, Gontijo JAR, Brazilian Journal of Medical and Biological Research 2001 34 1155 1160 (Pubitemid 33632099)
8. Exercise counteracts fatty liver disease in rats fed on fructose-rich diet. Botezelli JD, Moura RF, Dalia RA, Moura LP, Cambri LT, Ghezzi AC, VOltarelli FA, Mello MAR, Lipids in Health and Disease 2010 9 116
9. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Brooks N, Layne JE, Gordon PL, Roubenoff R, Nelson ME, Castaneda-Sceppa C, International Journal of Medicine Science 2007 4 19 27 (Pubitemid 46066235)
10. Analysis of serial measurements in medical research. Matthews JNS, Altman DG, Campbell MJ, British Medical Journal 1990 27 230 250
11. Components of AIN-93 diets as improvement in the AIN-76A diet. Reeves PG, J Nutr 1997 127 Suppl. 5 838S 841S (Pubitemid 27209452)
12. Standardization of insulin immunoassays: Report of the American Diabetes Association Workgropu. Marcovina S, Bowsher RR, Miller WG, Staten M, Myers G, Caudill SP, Campbell SE, Steffes MW, Chinical Chemistry 2007 53 Suppl. 4 711 716 (Pubitemid 46580242)
13. Estimates of invivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, et al. Journal of Clinical Endocrinology and Metabology 1989 68 374 378 (Pubitemid 19052880)
14. Estimation of an individual equilibrium between lactate production and catabolism during exercise. Tegtbur U, Busse MW, Braumann KL, Medicine & Science in Sports Exercise 1993 25 Suppl. 5 620 627 (Pubitemid 23138082)
15. Protocols for hyperlactatemia induction in the lactate minimum test adapted to swimming rats. Araujo GG, Papoti M, Manchado FB, Mello MAR, Gobatto CA, Comp Biochem Physiol A Mol Integrative Physiology 2007 148 Suppl. 4 888 892 (Pubitemid 350101302)
16. Causes and elimination of erratic blanc in enzymatic metabolic assays involving the use of NAD in alkaline hydrazine buffers: improved conditions for assay of L-glutamate, L-lactate and other metabolites. Engels RC, Jones JB, Annals of Biochemistry 1978 88 475 484 (Pubitemid 9061508)
17. Determination of anaerobic threshold in rats using the lactate minimum test. Voltarelli FA, Gobatto CA, Mello MAR, Brazilian Journal of Medical Biology Research 2002 35 Suppl. 11 1389 1394 (Pubitemid 36013591)
18. Clinical Biochemical Methods. Nogueira DM, Technical and interpretation São Paulo: Pancast 1990 263 266
19. A simple method for the isolation and purification of total lipids from animal tissues. Folch J, Lee M, Sloane Stanley GH, J Biol Chem 1956 23 497 509
20. Catalase in vitro. Aebi H, Methods Enzymol 1984 105 121 126
21. Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruoplasmin, and cooper levels in Behcets disease. Dögan P, Tanrikulu G, Soyuer Köse K, Clin Biochem 1994 5 413 418 (Pubitemid 24365914)
22. Optimized steps in fluorimetric determination of thiobarbituric acid-reactive substances in serum. Importance of extraction pH and influence of sample preservation and storage. Wasowicz W, Neve J, Perez A, Clin Chem 1993 39 Suppl. 12 2522 2526 (Pubitemid 24008241)
23. De novo synthesis of fatty acid in perfused rat liver as a determinant of plasma lipoprotein production. Windmueller HG, Spaeth AE, Biochem J 1967 122 Suppl. 2 362
24. Junqueira LCU, Junqueira LMMS, Basic techniques of cytology and histology Santos: São Paulo 1993
25. Fructose, weight gain, and the insulin resistance syndrome. Eliot SS, Keim NL, Stern J, Karen T, Havel PJ, Am J Clin Nutr 2002 76 911 922 (Pubitemid 35244659)
26. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Bray GA, Nielsen SJ, Popkin BM, Am J Clin Nutr 2004 79 537 543 (Pubitemid 41103894)
27. Dietary fructose and metabolic syndrome. Koshrow A, Abigale M, Gastroenterology 2008 24 Suppl. 2 204 209
28. Impact of early fructose intake on Metabolic profile and aerobic capacity of rats. Ghezzi AC, Cambri LT, Ribeiro C, Botezelli JD, Mello MAR, Lipids in Health and Disease 2011 10 Suppl. 3 1
29. Capacidade aerábia de ratos alimentados com dieta rica em frutose. Moura RF, Cambri LT, Quadros AC, Nascimento CMC, Arantes LM, Sebastião E, Tanaka K, Papini CB, Oliani MM, Motta CSA, Ribeiro C, Mello MAR, Brazilian Journal of Sports Medicine 2008 14 Suppl. 5 422 426
30. Markers of capacity utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. Simoneau JA, Veerkhamp JH, Turcotte LP, Kelley DE, FASEB Journa 1999 13 Suppl. 14 2051 2060 (Pubitemid 29517635)
31. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. He J, Watkins S, Kelley DE, Diabetes 2001 50 817 823 (Pubitemid 32242639)
32. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance and NIDDM. Simoneau JA, Kelley D, J Appl Physiol 1997 83 166 171 (Pubitemid 27304746)
33. Tissue-specific regulation of mitochondrial and sarcoplasmic protein synthesis rates by insulin. Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS, Diabetes 2001 56 2652 2658 (Pubitemid 33733114)
34. Aerobic capacity of rats recovered from fetal malnutrition with a fructose rich diet. Cambri L, Dalia RA, Ribeiro C, Mello MAR, Appl Physiol Nutr Metab 2010 35 490 497
35. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Rutledge AC, Adeli K, Nutr Rev 2007 65 Suppl. 6 13 S23
36. Fructose, insulin resistance, and metabolic dyslipidemia. Basciano H, Federico L, Khosrow A, Nutrition and Metabolism 2005 2 5 19
37. Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Huang X, Eriksson KF, Vaag A, Lehtovirta M, Hansson M, Laurila E, Kanninen T, Olesen BT, Kurucz I, Koranyi L, Groop L, Diabetes 1999 48 1508 1514 (Pubitemid 29356856)
38. Consuming fructose-sweetened beverages increases body adiposity in mice. Jurgens H, Haass W, Castãeda TR, Schürmann A, Koebnick C, Dombrowski F, Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HG, Havel PJ, Tschöp H, Obes Res 2005 13 1146 1156
39. Molecular mediators of hepatic steatosis and liver injury. Browning JD, Horton JD, J Clin Invest 2004 114 Suppl. 2 147 152 (Pubitemid 39071617)
40. Mitochondrial abnormalities in non-alcoholic steatohepatitis. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parked WD Jr, J Hepatol 1999 31 430 434 (Pubitemid 29408724)
41. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. Johnson EF, Palmer CN, Griffin KJ, Hsu MH, FASEB J 1996 10 41 1248
42. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Esterbauer H, Schaur RJ, Zollner H, Free Radic Biol Med 1991 11 81 128 (Pubitemid 121003917)
43. Fructose-enriched diet modifies antioxidant status and lipid metabolism in spontaneously hypertensive rats. Girard MS, Madani S, Boukortt F, Cherkaoui-Malki M, Belleville J, Prost J, Nutrition 2006 22 758 766 (Pubitemid 43947510)
44. Increased oxidative stress in rat liver and pancreas during progression of strepcototozocin-induced diabetes. Kakkar R, Mantha SV, Radhi J, Prasad K, Jawahar K, Clin Sci 1998 94 623 632 (Pubitemid 28269062)
45. Nonalcoholic fatty liver disease: A practical approach to evaluation and management. Rafik N, Zobair M, Younossi ZM, Clinical Liver Disease 2009 13 249 266
46. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Samuel VT, Liu Z-X, Qu X, Benjamin ED, Bilz S, Befroy D, Romanelli AJ, Shulman GI, J Biol Chem 2004 279 32345 32353 (Pubitemid 39014687)
47. Association of metabolic syndrome with both vigorous and moderate physical activity. Rennie KL, McCarthy N, Yazdgerdi, Mrmot M, Brunner E, International Journal of Epidemiology 2003 32 600 606 (Pubitemid 37039015)
48. Macronutrients, fat mass, fat acid flux and insulin sensitivity. Ziegler O, Quilliot D, Guerci, Drouni P, Diabetes Metabolism 2001 27 261 270
49. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Bergman RN, Ader M, Trends in Endocrinology and Metabolism 2000 11 351 356
50. A high-fat fiet and regulatory T-cells influence susceptibility to endotoxin liver injury. Ma X, Hua J, Mohamood AR, Hamad ARA, Ravi R, Li Z, Hepatology 2007 46 Suppl.5 1519 1529 (Pubitemid 350155534)
51. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. Robertson RP, J Biol Chem 2005 272 Suppl. 41 42351 42354
52. Role of apoptosis in failure beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS, Diabetes 1998 47 358 364 (Pubitemid 28104196)